[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![$tshas Graphic](https://lunarcrush.com/gi/w:26/t:$tshas.png) $tshas

BofA reiterates a Buy rating for $TSHA with a price target of $X. Community engagement remains positive despite market fluctuations, with KOLs expressing excitement for the gene therapy class in Rett.

### About $tshas
A cryptocurrency.  

### Insights [#](/topic/$tshas/insights)
- $tshas engagements is up XXXXX% from the previous week.

### Engagements: XX [#](/topic/$tshas/interactions)
---
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$tshas/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$tshas/time-series/interactions.tsv)  
**Current Value**: XX  
**Daily Average**: XX  
**1 Week**: XXX +31%  
**1 Month**: XXX -XX%  
**1-Year High**: XXX on 2025-09-05  
**1-Year Low**: X on 2025-10-17  

| Social Network | X  |
| -------------- | -  |
| Engagements    | XX |
  

  
  
### Mentions: X [#](/topic/$tshas/posts_active)
---
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$tshas/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$tshas/time-series/posts_active.tsv)  
**Current Value**: X  
**Daily Average**: X  
**1-Year High**: X on 2025-10-16  
**1-Year Low**: X on 2025-09-05  

| Social Network | X |
| -------------- | - |
| Mentions       | X |
  

  
  
### Creators: X [#](/topic/$tshas/contributors_active)
---
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$tshas/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$tshas/time-series/contributors_active.tsv)  
X unique social accounts have posts mentioning $tshas in the last XX hours which is no change from in the previous XX hours
**Daily Average**: X  
**1-Year High**: X on 2025-09-05  
**1-Year Low**: X on 2025-09-05  

The most influential creators that mention $tshas in the last XX hours

| Creator                                    | Rank | Followers | Posts | Engagements |
| -------                                    | ---- | --------- | ----- | ----------- |
| [@Quantumup1](/creator/twitter/Quantumup1) | X    | XXXXX     | X     | XX          |

[View More](/list/creators/$tshas/100)

**Top assets mentioned**
In the posts about $tshas in the last XX hours

[Acadia Pharmaceuticals Inc. (ACAD)](/topic/$acad)

**Top topics mentioned**
In the posts about $tshas in the last XX hours

[$tsha](/topic/$tsha), [$ngne](/topic/$ngne), [$acad](/topic/$acad), [has been](/topic/has-been), [$13b](/topic/$13b)

### Top Social Posts [#](/topic/$tshas/posts)
---
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"Citizens reiterated $TSHA Market Outperform-$6 and said We continue to highlight TSHA as an opportunity based on the efficacy in Rett clean safety (non-systemic) and regulatory clarity. $NGNE $ACAD Citizens JMP added: A key consideration for investors interested in TSHA has been comparison to NGNE the most relevant Rett gene therapy competitor. We continue to see distinct differences between the Rett clinical strategies of TSHA and NGNE and supportive data: Overall both TSHA & NGNE maintain that their asset has better biodistribution with their chosen administration routeintrathecal lumbar"  
[X Link](https://x.com/Quantumup1/status/1977759949179531382) [@Quantumup1](/creator/x/Quantumup1) 2025-10-13T15:34Z 3843 followers, 1418 engagements


"BofA $TSHA's PT to $X from $X and reiterated at a Buy. BofA currently assigns TSHA-102 a XX% LoS & XX% mkt shr for peak risk-adj'd sales of $1.3B in '31 ('27 launch) whereas its KOLs think the geneTx could capture XX% of mkt. $ACAD $NGNE Here's what BofA had to say: We continue to be encouraged by the regulatory alignment and highlight recent from our KOLs that the study is likely to be successful as they see significant see significant readthrough from the positive Part A study. Our KOLs cite high excitement for the gene therapy class in Rett viewing the current clinical data as clearly"  
[X Link](https://x.com/Quantumup1/status/1976321652204982750) [@Quantumup1](/creator/x/Quantumup1) 2025-10-09T16:19Z 3842 followers, 5454 engagements